Latest News

Boise Cascade (BCC) is back in focus after first quarter 2026 results showed lower sales and net income versus a year earlier, even as the company exceeded revenue and EPS expectations and issued cautious EBITDA guidance. See our latest analysis for Boise Cascade. At a share price of US$72.76, Boise Cascade has seen recent share price pressure, with a 7 day share price return of 8.21% and a 90 day share price return of 20.07%. The 1 year total shareholder return of 17.92% contrasts with...

If you are wondering whether Revvity at around US$98.85 is offering value or is simply noise in your watchlist, this breakdown can help frame what the current price might be implying. The stock has been active recently, with returns of 14.1% over 7 days, 12.6% over 30 days, 0.7% year to date and 6.7% over 1 year, alongside longer term returns of a 15.8% decline over 3 years and a 29.2% decline over 5 years. These mixed returns indicate short term optimism combined with longer term caution,...

In early May 2026, Artivion, Inc. reported first‑quarter revenue of US$116.34 million, up from US$98.98 million a year earlier, and moved from a small net loss to a net income of US$1.42 million while also announcing plans to acquire Endospan following FDA approval of the NEXUS Aortic Arch System. Despite this topline growth and portfolio expansion, Artivion missed profit expectations and lowered its full‑year 2026 revenue and adjusted EBITDA guidance, highlighting near‑term operational...

Why Madison Square Garden Sports (MSGS) is Back on Investor Radars Madison Square Garden Sports (MSGS) stock has been drawing fresh attention after posting annual revenue of US$1,071.0 million and net income of US$16.6 million, prompting investors to reassess how this professional sports company is currently valued. See our latest analysis for Madison Square Garden Sports. At a share price of US$332.52, Madison Square Garden Sports has seen a 19.06% 90 day share price return and a 74.18% 1...

In early May 2026, Gilead Sciences reported first-quarter revenue of US$6.96 billion and net income of US$2.02 billion, while also completing a multi-year US$4.57 billion share repurchase program and filing a US$6.51 billion shelf registration for up to 47,750,000 common shares. At the same time, the FDA accepted Gilead’s New Drug Application for its once-daily bictegravir/lenacapavir HIV regimen with priority review, underscoring how strong HIV portfolio performance and an advancing...

Why Crane NXT stock is back in focus after Q1 Crane NXT (CXT) is drawing fresh attention after first quarter 2026 revenue and adjusted earnings topped expectations, helped by the Antares Vision acquisition and firm demand in Security and Authentication Technologies. See our latest analysis for Crane NXT. The latest results and acquisition update have arrived after a mixed share price run, with a 30 day share price return of 5.40% but a 1 year total shareholder return decline of 12.80%. If Q1...

BlackLine, Inc. recently reported first-quarter 2026 results, with GAAP revenue of US$183.16 million and net income of US$8.13 million, and issued guidance calling for second-quarter GAAP revenue of US$186 million to US$188 million and full-year 2026 GAAP revenue of US$765 million to US$769 million. Management’s decision to raise full-year guidance and highlight growing adoption of its AI-powered financial automation platform underlines how operational progress is increasingly shaping...

Arista Networks (ANET) moved into focus after first quarter 2026 results and fresh guidance highlighted strong AI networking demand along with ongoing supply constraints, leaving the stock volatile as investors reassessed growth expectations. See our latest analysis for Arista Networks. The shares have swung sharply, with a 7 day share price return of negative 17.9% and a 1 day move of negative 3.6%. This is in contrast to the 1 year total shareholder return of 62.4% and the 5 year total...

Earlier this year, Money Forward reported strong Q1 results, with net sales and SaaS ARR rising and the company lifting its full-year sales and ARR outlook despite continuing to project operating and net losses. An interesting angle is that EBITDA has improved while Money Forward keeps advertising and personnel expenses high relative to sales to support ongoing expansion. Next, we’ll examine how the raised full-year guidance, supported by higher SaaS ARR, may influence Money Forward’s...

CarGurus, Inc. has now reported its past first-quarter 2026 results, posting sales of US$243.56 million versus US$212.24 million a year earlier, while net income eased to US$32.23 million from US$39.05 million and diluted EPS from continuing operations slipped to US$0.34 from US$0.40. Alongside this, CarGurus highlighted AI-led product investment, broader premium-tier adoption, a multi-year NASCAR Canada partnership, new data-driven Confidence Awards, and ongoing share repurchases,...

In April 2026, NRSInsights, an IDT Corporation subsidiary, reported a 3.9% year-over-year increase in same-store sales and a 13% rise in transaction values to US$2.20 billion, while chairman Howard S. Jonas disclosed several bona fide gifts of Class B Common Stock. The combination of stronger retail sales metrics at NRS and insider gifting activity underscores the growing operational weight of IDT’s retail data and payments platform within the group. We’ll now examine how NRSInsights’...

Zymeworks Inc. recently reported first-quarter 2026 results showing a wider net loss of US$44.16 million and a basic loss per share of US$0.59 as lower milestone revenue weighed on earnings. At the same time, the company underscored its upcoming August 2026 FDA Priority Review decision for zanidatamab and a cash runway it expects to extend beyond 2028, supported by royalty financing and share repurchases. Now we will examine how the widened quarterly loss alongside the imminent zanidatamab...

Why Mitsubishi UFJ Financial Group (TSE:8306) is on investor radars today Mitsubishi UFJ Financial Group (TSE:8306) has drawn fresh attention after recent share price moves, with the stock showing a negative return over the past 3 months but a positive year to date performance. See our latest analysis for Mitsubishi UFJ Financial Group. The recent pullback, including a 4.9% decline in the 90 day share price return and a 1.3% 30 day share price return decline, sits alongside a 10.3% year to...

Toast (TOST) is back in focus after Q1 2026 results, with revenue of US$1.63b and net income of US$126m, updated guidance, fresh AI products, and new high-profile hospitality partnerships. See our latest analysis for Toast. The share price reaction around Q1, including the recent 3.8% 1-day and 13.1% 30-day share price returns, points to improving short-term momentum, even though the year-to-date share price return of 13.6% and 1-year total shareholder return of 19.8% remain weak against a...

Graham Holdings Company recently reported first-quarter 2026 results showing year-over-year increases in revenue to US$1.24 billion and net income to US$29.11 million, alongside updates on its ongoing share repurchase program, while also declaring a regular quarterly dividend of US$1.88 per share payable in August 2026. Together with the election of all director nominees and shareholder support for 2025 executive compensation, these moves highlight how Graham Holdings is combining capital...

Why Kubota’s latest earnings are on investors’ radar Kubota (TSE:6326) has moved into focus after a strong first quarter earnings release, with double digit revenue and profit growth, reaffirmed 2026 guidance, and an unchanged dividend forecast that together underline management confidence. See our latest analysis for Kubota. The strong earnings update appears to have fed directly into sentiment, with a 1-day share price return of 4.22% and a year to date share price return of 25.51%. The...

Houlihan Lokey (HLI) is back in focus after reporting record fiscal 2026 revenue, announcing a higher quarterly dividend, and posting a fourth quarter that missed analyst earnings and revenue expectations, creating a mixed signal for investors. See our latest analysis for Houlihan Lokey. The share price reaction reflects this mixed message, with a 1 day share price return of 4.26% after the earnings and dividend news, but a year to date share price decline of 12.95% alongside a 5 year total...

In early May 2026, Driven Brands Holdings Inc. disclosed that it would miss the SEC deadline for filing its Q1 2026 Form 10-Q as it continues restating prior years’ financial statements following the discovery of material accounting errors and internal control weaknesses. This delay, combined with a series of securities class action lawsuits alleging misleading financial reporting and ineffective controls, places Driven Brands’ governance and financial transparency under intense scrutiny...

In the past quarter, MasterBrand, Inc. reported Q1 2026 sales of US$618 million, down from US$660.3 million a year earlier, and moved from a net income of US$13.3 million to a net loss of US$15.4 million. Alongside weaker results, the company guided to a further mid- to high-single-digit year-over-year sales decline for Q2 2026 and confirmed it repurchased 226,914 shares under its 2025 buyback plan while advancing cost cuts and tariff mitigation as it works toward a merger with American...

Braze (BRZE) has announced a series of senior leadership moves, with Chief Financial Officer Isabelle Winkles set to leave after the current quarter, while Chief Accounting Officer Pankaj Malik steps in as interim CFO. See our latest analysis for Braze. At a share price of US$22.60, Braze has a 90 day share price return of 27.04%, set against a year to date share price decline of 30.57% and a 1 year total shareholder return decline of 32.86%. This suggests that recent momentum has picked up...

Emera (TSX:EMA) is back in focus after reporting first quarter 2026 results that featured a 7% rise in adjusted EPS and management commentary that it is on track to surpass its 5% to 7% EPS growth target. See our latest analysis for Emera. The strong first quarter update and plan to redeem CA$1.2b of subordinated notes come after a 90 day share price return of 5.74% and a 1 year total shareholder return of 20.39%. This suggests that momentum has been building rather than fading. If you are...

Clinical data spotlight on cardiac technologies Boston Scientific (BSX) is back in focus after new clinical results for its FARAPULSE PFA and WATCHMAN LAAC platforms were presented at Heart Rhythm 2026, bringing real world atrial fibrillation and stroke risk reduction outcomes to investors. See our latest analysis for Boston Scientific. Despite the encouraging clinical headlines and corporate activity around governance changes, institutional ownership updates and a new US$565.7m shelf...

In early May 2026, The Walt Disney Company reported fiscal Q2 results showing revenue of US$25.17 billion, up from US$23.62 billion a year earlier, while net income declined to US$2.25 billion from US$3.28 billion and earnings per share also decreased, alongside confirmation of share repurchases totaling 112,376,398 shares for US$12.06 billion since February 2024. The earnings release doubled as new CEO Josh D’Amaro’s first major update, highlighting plans to make Disney+ the central hub...

In late April 2026, SoftBank Corp. announced it had jointly developed with TOPPAN Holdings a lightweight, highly durable wing skin and testing method for solar-powered High-Altitude Platform Station (HAPS) aircraft, aiming for test production and broader use ahead of SoftBank’s planned commercial HAPS services from 2029. By combining TOPPAN’s multi-layer film and durability testing expertise with SoftBank’s stratospheric flight data, the partners created materials that can withstand extreme...